Literature DB >> 27163757

Interferon Gamma and Contact-dependent Cytotoxicity Are Each Rate Limiting for Natural Killer Cell-Mediated Antibody-dependent Chronic Rejection.

C M Lin1, R J Plenter2, M Coulombe3, R G Gill3.   

Abstract

Natural killer (NK) cells are key components of the innate immune system. In murine cardiac transplant models, donor-specific antibodies (DSA), in concert with NK cells, are sufficient to inflict chronic allograft vasculopathy independently of T and B cells. In this study, we aimed to determine the effector mechanism(s) required by NK cells to trigger chronic allograft vasculopathy during antibody-mediated rejection. Specifically, we tested the relative contribution of the proinflammatory cytokine interferon gamma (IFN-γ) versus the contact-dependent cytotoxic mediators of perforin and the CD95/CD95L (Fas/Fas ligand [FasL]) pathway for triggering these lesions. C3H/HeJ cardiac allografts were transplanted into immune-deficient C57BL/6 rag-/- γc-/- recipients, who also received monoclonal anti-major histocompatibility complex (MHC) class I DSA. The combination of DSA and wild-type NK cell transfer triggered aggressive chronic allograft vasculopathy. However, transfer of IFN-γ-deficient NK cells or host IFN-γ neutralization led to amelioration of these lesions. Use of either perforin-deficient NK cells or CD95 (Fas)-deficient donors alone did not alter development of vasculopathy, but simultaneous disruption of NK cell-derived perforin and allograft Fas expression resulted in prevention of these abnormalities. Therefore, both NK cell IFN-γ production and contact-dependent cytotoxic activity are rate-limiting effector pathways that contribute to this form of antibody-induced chronic allograft vasculopathy. © Copyright 2016 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  animal models: murine; basic (laboratory) research/science; cytokines/cytokine receptors; immunobiology; natural killer (NK) cells/NK receptors; rejection: antibody-mediated (ABMR); rejection: chronic

Mesh:

Substances:

Year:  2016        PMID: 27163757      PMCID: PMC5083186          DOI: 10.1111/ajt.13865

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  55 in total

1.  Morphometric analysis of neointimal formation in murine cardiac allografts: II. Rate and location of lesion development.

Authors:  A T Armstrong; A R Strauch; R C Starling; D D Sedmak; C G Orosz
Journal:  Transplantation       Date:  1997-07-27       Impact factor: 4.939

Review 2.  Activation of NK cell cytotoxicity.

Authors:  Mark J Smyth; Erika Cretney; Janice M Kelly; Jennifer A Westwood; Shayna E A Street; Hideo Yagita; Kazuyoshi Takeda; Serani L H van Dommelen; Mariapia A Degli-Esposti; Yoshihiro Hayakawa
Journal:  Mol Immunol       Date:  2005-02       Impact factor: 4.407

Review 3.  How do cytotoxic lymphocytes kill their targets?

Authors:  S Shresta; C T Pham; D A Thomas; T A Graubert; T J Ley
Journal:  Curr Opin Immunol       Date:  1998-10       Impact factor: 7.486

Review 4.  IgG Fc receptors.

Authors:  J V Ravetch; S Bolland
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

5.  The technique for heterotopic cardiac transplantation in mice: experience of 3000 operations by one surgeon.

Authors:  M Niimi
Journal:  J Heart Lung Transplant       Date:  2001-10       Impact factor: 10.247

6.  Roles for common cytokine receptor gamma-chain-dependent cytokines in the generation, differentiation, and maturation of NK cell precursors and peripheral NK cells in vivo.

Authors:  Christian A J Vosshenrich; Thomas Ranson; Sandrine I Samson; Erwan Corcuff; Francesco Colucci; Eleftheria E Rosmaraki; James P Di Santo
Journal:  J Immunol       Date:  2005-02-01       Impact factor: 5.422

Review 7.  NK cells: elusive participants in transplantation immunity and tolerance.

Authors:  Ronald G Gill
Journal:  Curr Opin Immunol       Date:  2010-10-15       Impact factor: 7.486

8.  Localization of Fas ligand in cytoplasmic granules of CD8+ cytotoxic T lymphocytes and natural killer cells: participation of Fas ligand in granule exocytosis model of cytotoxicity.

Authors:  Yuko Kojima; Akemi Kawasaki-Koyanagi; Noriyoshi Sueyoshi; Atsushi Kanai; Hideo Yagita; Ko Okumura
Journal:  Biochem Biophys Res Commun       Date:  2002-08-16       Impact factor: 3.575

9.  National conference to assess antibody-mediated rejection in solid organ transplantation.

Authors:  Steven K Takemoto; Adriana Zeevi; Sandy Feng; Robert B Colvin; Stanley Jordan; Jon Kobashigawa; Jerzy Kupiec-Weglinski; Arthur Matas; Robert A Montgomery; Peter Nickerson; Jeffrey L Platt; Hamid Rabb; Richard Thistlethwaite; Dolly Tyan; Francis L Delmonico
Journal:  Am J Transplant       Date:  2004-07       Impact factor: 8.086

10.  Homeostatic proliferation generates long-lived natural killer cells that respond against viral infection.

Authors:  Joseph C Sun; Joshua N Beilke; Natalie A Bezman; Lewis L Lanier
Journal:  J Exp Med       Date:  2011-01-24       Impact factor: 14.307

View more
  14 in total

1.  In the absence of natural killer cell activation donor-specific antibody mediates chronic, but not acute, kidney allograft rejection.

Authors:  Takafumi Yagisawa; Toshiaki Tanaka; Satoshi Miyairi; Kazunari Tanabe; Nina Dvorina; Wayne M Yokoyama; Anna Valujskikh; William M Baldwin; Robert L Fairchild
Journal:  Kidney Int       Date:  2018-11-29       Impact factor: 10.612

2.  Fingering a Natural Culprit During Antibody-Mediated Rejection.

Authors:  Robert L Fairchild
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

Review 3.  Recent advances in allograft vasculopathy.

Authors:  Jonathan Merola; Daniel D Jane-Wit; Jordan S Pober
Journal:  Curr Opin Organ Transplant       Date:  2017-02       Impact factor: 2.640

4.  Apelin directs endothelial cell differentiation and vascular repair following immune-mediated injury.

Authors:  Andrew G Masoud; Jiaxin Lin; Abul K Azad; Maikel A Farhan; Conrad Fischer; Lin F Zhu; Hao Zhang; Banu Sis; Zamaneh Kassiri; Ronald B Moore; Daniel Kim; Colin C Anderson; John C Vederas; Benjamin A Adam; Gavin Y Oudit; Allan G Murray
Journal:  J Clin Invest       Date:  2020-01-02       Impact factor: 14.808

Review 5.  Antibody-mediated rejection across solid organ transplants: manifestations, mechanisms, and therapies.

Authors:  Nicole M Valenzuela; Elaine F Reed
Journal:  J Clin Invest       Date:  2017-06-12       Impact factor: 14.808

6.  Bringing Clarity to the Murky Problem of Cardiac Allograft Vasculopathy.

Authors:  Ronald G Gill
Journal:  Am J Pathol       Date:  2022-05-14       Impact factor: 5.770

7.  Deletion of the activating NK cell receptor NKG2D accelerates rejection of cardiac allografts.

Authors:  Cornelia Fabritius; Paul Viktor Ritschl; Thomas Resch; Mario Roth; Susanne Ebner; Julia Günther; Vanessa Mellitzer; Anh-Vu Nguyen; Johann Pratschke; Martina Sauter; Karin Klingel; Katja Kotsch
Journal:  Am J Transplant       Date:  2017-09-09       Impact factor: 8.086

8.  The natural killer cell activating receptor, NKG2D, is critical to antibody-dependent chronic rejection in heart transplantation.

Authors:  Christine M Lin; Ronald G Gill; Borna Mehrad
Journal:  Am J Transplant       Date:  2021-06-17       Impact factor: 9.369

Review 9.  Not All Antibodies Are Created Equal: Factors That Influence Antibody Mediated Rejection.

Authors:  Carrie L Butler; Nicole M Valenzuela; Kimberly A Thomas; Elaine F Reed
Journal:  J Immunol Res       Date:  2017-03-08       Impact factor: 4.818

10.  Non-ischemic Heart Preservation via Hypothermic Cardioplegic Perfusion Induces Immunodepletion of Donor Hearts Resulting in Diminished Graft Infiltration Following Transplantation.

Authors:  William R Critchley; John P Stone; Qiuming Liao; Guangqi Qin; Ivar Risnes; Andrew Trafford; Helge Scott; Trygve Sjöberg; Stig Steen; James E Fildes
Journal:  Front Immunol       Date:  2020-07-28       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.